2. Fruhmorgen P., Reidenback M.D., Boden F. et al. Experimental examination on laser endoscopy. Endoscopy 1974;6:116–122.

3. Brunetaud J.M., Maffioli C., Enger A. et al. Endoscopic laser coagulation in the digestive tract: Development of a photocoagulation and experimental study. Laser 77, IPC Science and Technology, Guilford. 1977;355– 360.

4. Brunetaud J.M., Moschetto Y., Lenoir P. et al. Les applications thérapeutiques des lasers: une nouvelle génération de fibres. Photon 1980. Proceedings: 285–291.

5. Lenz P., Sabben G., Lambert R. et al. Quartz fibers laser therapy in tissue contact. Photon 1983, May 16–19, 1983, Paris. SPIE Proceedings, 405: 97–104.

6. Joffe S.N., Sankar M.Y., Slazer D. et al. Preliminary clinical application of the contact surgical rod and endoscopic microprobes with the Nd:YAG laser. American Society for Laser Medicine and Surgery, May 27–29, 1985.

7. Staehler G., Schmiedt E., Hofstetter A. Destruction of bladder neoplasms by means of transurethral neodym-YAG-laser coagulation. Helv Chir Acta. 1978;45(3):307–311.

8. Kawada T., Ebihara K., Suzuki T. et al. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol. 1997;157(6):2225–2226.

9. Kramer M.W., Rassweiler J.J., Klein J. et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol. 2015;33(12):1937–1943. Doi: 10.1007/s00345-015-1568-6. PMID: 25910478.

10. Luo Y., Cao Z.G., Liu J., Su J.H., Zhu J.G., Xu Z. A comparison of clinical outcome between holmium laser resection and transurethral resection for superficial bladder carcinoma. Tumor. 2008,28:1001–1003.

11. Gravas S., Bachmann A., Reich O., Roehrborn C.G., Gilling P.J., De La Rosette J. Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int. 2011;107:1030–1043.

12. Mahdavifar N., Momenimovahed Z., Salehiniya H., Epidemiology, Incidence and Mortality of Bladder Cancer and their Relationship with the Development Index in the World. Asian. Pac. J. Cancer Prev. 2016;17(1):381–386.

13. Klotz L., World urologic oncology federation bladder cancer prevention program: a global initiative. Urologic oncology. 2015;33:25–29.

14. Ferlay J., Cancer incidence and mortality worldwide: sources, methods and major patterns in Globocan 2012. International Journal of Cancer. 2015;136:359–386.

15. Mahdavifar N., Momenimovahed Z., Salehiniya H., Epidemiology, Incidence and Mortality of Bladder Cancer and their Relationship with the Development Index in the World. Asian. Pac. J. Cancer Prev. 2016;17(1):381–386.

16. Martin C. S., The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Scientific Reports. 2018; Article number:1129.

17. Leal J. Economic burden of bladder cancer across the European Union Eur. Urol. 2016; 69:438–447.

18. Fitzmaurice C. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1:505–527.

19. Antoni S. Bladder cancer incidence and mortality: a global overview and recent trends. Eur. Urol. 2017;71:96–108.

20. Siegel R.L. Cancer statistics, 2018. The Cancer Journal for Clinicians. 2018; 68:7–30.

21. Kaprin A.D., StarinskijV.V., Petrova.G.V. Malignant neoplasms in Russia in 2016 (morbidity and mortality). M.: FGBU «MNIOI im. P.A. Gercena» Minzdrava Rossii, 2018; 250 р. Russian (Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2016 году (заболеваемость и смертность). М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России. 2018;250 с.).

22. Babjuk M. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur. Urol. 2017;71: 447-61.

23. Lopatkin N.A., Martov A.G., Krendel’ B.M. Modern approaches in the treatment of superficial bladder cancer. In the book: Bladder cancer: materials of the 4th All-Russian scientific. conf. with the participation of the CIS countries. M.: 2002;50–51. Russia (Лопаткин Н. А., Мартов А. Г., Крендель Б. М. Современные подходы в лечении поверхностного рака мочевого пузыря. В кн.: Рак мочевого пузыря: материалы 4-й Всероссийской науч. конф. с участием стран СНГ. M.: 2002;50–51).

24. Protoschak V.V., Kukushkin A.V., Babkin P.A. Intravesical therapy for bladder cancer: current state of the art. Oncourology. 2011; 3: 37-143. Russian (Протощак В.В., Кукушкин А.В., Бабкин П.А. Внутрипузырная терапия рака мочевого пузыря: современное состояние проблемы. Онкоурология. 2011;3:37–143).

25. Kassouf W. CUA guidelines on the management of non-muscle invasive bladder cancer. Canadian Urological Association Journal. 2015;9(9-10):E690-E704.

26. Martov A.G., Ergakov D.V., Bajkov N.A. Transurethral removal of bladder tumors in a single block. Oncourology. 2015;1:41-49. Russian. (Мартов А.Г., Ергаков Д.В., Байков Н.А. Трансуретральное удаление опухолей мочевого пузыря единым блоком. Онкоурология. 2015;1:41-49).

27. Hurle R. «En Bloc» Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study. Urology. 2016.90:126.

28. Kang W. Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis. Oncotarget. 2017;8(14):23880–23890.

29. Babjuk, M. Клинические рекомендации по неинвазивному раку мочевого пузыря (Ta, T1 и карцинома in situ). Клинические рекомендации Европейской ассоциации урологов. EAU, 2020:25–56.

30. Kassouf, W. CUA guidelines on the management of non-muscle invasive bladder cancer. Canadian Urological Association Journal. 2015;9(9–10):E690-E704.

31. Rolevich A.I. Prognostic classification for bladder cancer without muscle invasion. Journal of Oncology (Minsk). 2016;10:64–67. Russian (Ролевич А.И. Прогностическая классификация при раке мочевого пузыря без мышечной инвазии. Онкологический журнал (Минск). 2016;10:64–67).

32. Kaprin A.D., Starinskiy V.V., Petrova G.V. State of cancer care to the population of Russia in 2015. M.: FGBU «MNIOI im. P.A. Herzen »of the Ministry of Health of Russia. 2016; 236 р. Russian (Каприн А.Д., Старинский В.В., Петрова Г.В.. Состояние онкологической помощи населению России в 2015 г. М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России. 2016; 236 с).

33. Brausi M. Management of high-risk non-muscle invasive bladder cancer. Minerva Urol. Nefrol. 2012 Dec;64(4):255–260.

34. Avallone M.A. Ten-year review of perioperative complications after transurethral resection of bladder tumors: analysis of monopolar and plasmakinetic bipolar cases. J. Endourol. 2017.Aug; 31(8):767–773.

35. Jonler M., Lund L., Bisballe S. Holmium:YAG laser vaporization of recurrent papillary tumours of the bladder under local anaesthesia. BJU Int. 2004; 94:322–325.

36. Kramer M.W., Bach T., Wolters M. Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer. World J Urol. 2011;29:433–442.

37. Bai Y., Liu L., Yuan H., Li J., Tang Y., Pu C. Safety and efficacy of transurethral laser therapy for bladder cancer: a systematic review and meta-analysis .World J Surg Oncol. 2014;12:301.

38. Wendt-Nordahl G., Huckele S., Honeck P., Alken P., Knoll T., Michel M. S., Hacker A. Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol. 2008;22(5):1041–1045.

39. Wezel F., Wendt-Nordahl G., Huck N., Bach T., Weiss C., Michel M. S., Hacker New alternatives for laser vaporization of the prostate: experimental evaluation of a 980-, 1,318- and 1,470-nm diode laser device. World J Urol. 2010;28(2):181–186.

40. Huan Yang, Ning Wang, Shanfu Han, Musa Male, Chenming Zhao, Daqiang Yao, Zhiqiang Chen Lasers in Medical Science December. 2017;32(9):2005–2012.

41. Herrmann T. R., Liatsikos E. N., Nagele U., Traxer O., Merseburger A. S., Eau Guidelines Panel on Lasers T. EAU guidelines on laser technologies. Eur Urol. 2012;61(4):783–795.

42. Wei Wang, Haitao Liu, Shujie Xia. Thulium laser treatment for bladder cancer. Asian Journal of Urology. 2016;3(3):130-3.

43. Staehler G., Schmiedt E., Hofstetter A., Destruction of bladder neoplasms by means of transurethral neodym- YAG-laser coagulation. Helv Chir Acta. 1978; 45(3):307–311.

44. Wolters M., Kramer M.W., Becker J.U., Christgen M., Nagele U., Imkamp F. Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World. J. Urol. 2015;33(4):571–579.

45. Gao X., Ren S., Xu C., Thulium laser resection via a flexible cystoscope for recurrent non-muscleinvasive bladder cancer: initial clinical experience. Journal compilation bju international. 2008;102:1115–1118.

46. Kuntz R.M. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol. 2006;49:961–969.

47. Zhang X.R., Тwo-micrometer continuous-wave tulium laser treating primary non-muscle-invasive bladder cancer: Is It Feasible. A Randomized Prospective Study. Photomed Laser Surg. 2015;33(10):517–523.

48. Mariappan P., Mariappan P., Zachou A., Grigor K.M., Detrusor muscle in the rst, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010;57(5):843–849.

49. Koca O., Keles M. O., Kaya C., Gunes M., Ozturk M., Karaman M. I. Plasmakinetic vaporization versus transurethral resection of the prostate: Six-year results. Turk J. Urol.2014;40(3):134–137.

50. Gupta N.P., Saini A.K., Dogra P.N., Seth A., Kumar R. Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience. BJU Int. 2011;108(4):553-6.

51. Bai Y, Liu L, Yuan H, Li J, Tang Y, Pu C, Han P. Safety and efficacy of transurethral laser therapy for bladder cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology. 2014;12:301.

52. Teichmann H. O., Herrmann T. R., Bach T. Technical aspects of lasers in urology. World J Urol. 2007;25(3):221–225.

53. Kuntz R.M. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol. 2006;49:961–969.

54. Raschupkina E.V., Teodorovich O.V., Kochiev D.G., Andreeva Yu.Yu., Shatokhin M.N., Borisenko G.G., Naryshkin S.A. Experimental substantiation of the use of ND-YAG – laser coagulation of bladder tissue. Urologiia. 2015;3:55–59. Russian (Расщупкина Е.В., Теодорович О.В., Кочиев Д.Г., Андреева Ю.Ю., Шатохин М.Н., Борисенко Г.Г., Нарышкин С.А. Экспериментальное обоснование использования ND-YAG – лазерной коагуляции ткани мочевого пузыря. Урология. 2015;3:55–59).

55. Borota A.V., Konopko A.V., Anishchenko A.A., Dyachenko A.M., Chistyakov R.S. Methods of surgical treatment of invasive bladder cancer (literature review) Russian (Борота А.В., Конопко А.В., Анищенко А.А., Дьяченко А.М., Чистяков Р.С. Способы хирургического лечения инвазивного рака мочевого пузыря (обзор литературы). 2010;2(6):24–35).

56. Bach T., Huck N., Wezel F., Hacker A., Gross A. J., Michel M. S. 70 vs 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. BJU Int. 2010;106(3):368–372.

57. Krajewski W., Dołowy Ł., Dembowski J., Zdrojowy R., Kołodziej A. The role of lasers in modern urology Cent European J Urol. 2015;68:175–182.

58. Heinrich E., Wendt-Nordahl G., Honeck P., 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol. 2010;24:75–79.

59. Gravas S., Bachmann A., Reich O., Roehrborn C.G., Gilling P.J., De La Rosette J. Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int. 2011;107:1030–1043.

60. Chiang P.H., Chen C.H., Kang C.H., Chuang Y.C. Green Light HPS laser 120-W versus diode laser 200-W vaporization of the prostate: comparative clinical experience. Lasers Surg Med. 2010;42:624–629.

61. Huan Yang, Ning Wang, Shanfu Han, Musa Male, Chenming Zhao, Daqiang Yao, Zhiqiang Chen Lasers in Medical Science. 2017;32(9):2005–2012.

62. Chen C. H., Chiang P. H., Chuang Y. C., Lee W. C., Chen Y. T., Lee W. C. Preliminary results of prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-W high-intensity diode laser. Urology. 2010;75(3)658–663.

63. Bai Y., Liu L., Yuan H., Li J., Tang Y., Pu C. Safety and efficacy of transurethral laser therapy for bladder cancer: a systematic review and meta-analysis World J Surg Oncol. 2014;12:301.

64. He D., Fan J., Wu K., Novel green-light KTP laser en bloc enucleation for nonmuscle-invasive bladder cancer: technique and initial clinical experience. Journal of Endourology. 2014;28(8).

65. Teodorovich O.V., Shatokhin M.N., Abdullaev M.I., Krasnov A.V., Khommyatov M.R. Intersticial laser coagulation in the management of urothelial papillary carcinoma of the renal pelvis. Urologiia. 2018; 4: 122-26. Russian (Теодорович О.В., Шатохин М.Н., Абдуллаев М.И., Краснов А.В., Хоммятов М.Р. Интерстициальная лазерная коагуляция в лечении уротелиального папиллярного рака лоханки. Урология. 2018;4:122–126.

66. Kochiev D.G., Shcherbakov I.A., Naryshkin S.A., Teodorovich O.V. Methods and technologies of photonics in endosurgery. Optics and Spectroscopy. 2015; 119(3): 424-429. Russian. (Кочиев Д.Г., Нарышкин С.А., Теодорович О.В., Щербаков И.А. Методы и технологии фотоники в эндохирургии. Оптика и спектроскопия. 2015;119(3):424–429.